Product
Convalescent COVID 19 Plasma
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Assessment of the Safety of Convalescent Plasma to Treat COVID-19 Patients With Moderate and Above IllnessStatus: Completed, Estimated PCD: 2021-03-30